TrialHuman vaccines & immunotherapeutics2015

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults.

Masanari Shiramoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.